EDRONAX reboxetine 4mg

Product details Supply Impact Dates Further Details
EDRONAX reboxetine 4mg

AUST R: 79745

Active Ingredients: reboxetine mesilate

Dosage From: Tablet, uncoated
 From: 16 Mar 2026

To: 25 May 2026 		Shortage Status: Anticipated

Availability: Available

Reason: Commercial Changes / Commercial viability